Potassium-Enriched Salt in Hypertension، Meta-analysis 2026 (JACC) — Key Points
Potassium-Enriched Salt in Hypertension
Meta-analysis 2026 (JACC) — Key Points
Source :
ISH Bulletin (Hypertension News)
JACC (April 2026 )
Background
• High sodium ↑ BP & CVD
• Low potassium intake also contributes to hypertension
What is potassium-enriched salt?
• Replace part of NaCl with KCl
• Same taste → easy 1:1 switch
Benefits
• ↓ BP (↓ sodium + ↑ potassium)
• ↓ stroke & CV events (NEJM)
Guidelines
• Recommended in:
* ESC 2024
* AHA/ACC 2025
* WHO 2025
Caution
• Avoid in:
* Moderate–severe CKD
* Patients on K-sparing drugs
• Check renal function
🎯 Take-Home (Updated 2026)
Now guideline-supported (WHO + ESC + AHA/ACC)
JACC 2026 confirms effectiveness
Not just lifestyle advice → evidence-based intervention
One of the most scalable, high-impact prevention strategies
Source :
ISH Bulletin (Hypertension News)
🔗 https://ish-world.com/document/1764854372.pdf
JACC (April 2026 )
🔗 https://www.jacc.org/doi/10.1016/j.jacasi.2026.02.014
